Introduction —
This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Screening for colorectal cancer".)
●(See "Society guideline links: Hereditary colorectal cancer syndromes".)
●(See "Society guideline links: Colorectal surgery for cancer".)
●(See "Society guideline links: Gastrointestinal bleeding in adults".)
●(See "Society guideline links: Bowel obstruction".)
●(See "Society guideline links: Laparoscopic and robotic surgery".)
●(See "Society guideline links: Liver resection and ablation".)
●(See "Society guideline links: Colon polyps".)
International
●Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt): International management guidelines (2023)
●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer (2023)
●International harmonization of provisional diagnostic criteria for ERBB2-amplified metastatic colorectal cancer allowing for screening by next-generation sequencing panel (2020)
●European Society of Surgical Oncology (ESSO), European Society of Coloproctology (ESCP), International Society of Geriatric Oncology (SIOG), and American College of Surgeons (ACS) Commission on Cancer: Expert recommendations for personalized management of elderly patients with rectal cancer (2018)
Canada
●Choosing Wisely Canada: Don't routinely use extensive locoregional therapy in most cancer situations where there is metastatic disease and minimal symptoms attributable to the primary tumour (eg, colorectal cancer) (2024)
●Ontario Health (OH) (Cancer Care Ontario [CCO]): Adjuvant systemic chemotherapy for stage II and III colon cancer following complete resection (2024)
●OH (CCO): Continuous versus intermittent chemotherapy strategies in inoperable, advanced colorectal cancer (2022)
●OH (CCO): Follow-up care, surveillance protocols and secondary prevention measures for survivors of colorectal cancer (2021)
●OH (CCO): Regional therapies for colorectal cancer liver metastases (2020)
●CCO: Preoperative or postoperative therapy for the management on patients with stage II or III rectal cancer (2019)
●CCO: The role of primary tumour location in the selection of biologics for the treatment of unresectable metastatic colorectal cancer – An endorsement of a Canadian consensus statement (2018)
●CCO: Referral of patients with suspected colorectal cancer by family physicians and other primary care providers (2017)
●CCO: An evidence summary on the utility of PET/CT in colorectal cancer metastasis (2014)
●CCO: Optimization of preoperative assessment in patients diagnosed with rectal cancer (2014)
●CCO: Strategies of sequential therapies in unresectable, metastatic colorectal cancer treated with palliative intent (2014)
●CCO: PET imaging in colorectal cancer (2010)
United States
●American Society for Radiation Oncology (ASTRO): Clinical practice guideline on radiation therapy for rectal cancer, focused update (2024)
•ASTRO: Clinical practice guideline on radiation therapy for rectal cancer (2021)
●American Society of Clinical Oncology (ASCO): Guideline for the management of locally advanced rectal cancer (2024)
●American Society of Colon and Rectal Surgeons (ASCRS): Clinical practice guidelines for the management of rectal cancer, 2023 supplement (published 2024)
•ASCRS: Clinical practice guidelines for the management of rectal cancer (2020)
●ASCO: Guideline for the treatment of metastatic colorectal cancer (2022)
●ASCRS: Clinical practice guidelines for the management of colon cancer (2022)
●American College of Radiology (ACR): ACR Appropriateness Criteria on staging of colorectal cancer (2021)
●ASCO: Guideline on adjuvant therapy for stage II colon cancer, update (2021)
●ASCRS: Clinical practice guidelines for the surveillance and survivorship care of patients after curative treatment of colon and rectal cancer (2021)
●American Gastroenterological Association (AGA): Clinical practice update on young adult–onset colorectal cancer diagnosis and management – Expert review (2020)
●ASCO: Resource-stratified guideline for the treatment of patients with late-stage colorectal cancer (2020)
●ASCO: Clinical practice guideline on duration of oxaliplatin-containing adjuvant therapy for stage III colon cancer (2019)
●ASCO: Resource-stratified guideline for the treatment of patients with early-stage colorectal cancer (2019)
●ASCO: Resource-stratified guideline on early detection for colorectal cancer (2019)
●European Society of Surgical Oncology (ESSO), European Society of Coloproctology (ESCP), International Society of Geriatric Oncology (SIOG), and American College of Surgeons (ACS) Commission on Cancer: Expert recommendations for personalized management of elderly patients with rectal cancer (2018)
●American Society for Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and ASCO: Guideline on molecular biomarkers for the evaluation of colorectal cancer (2017)
●American Cancer Society (ACS): Colorectal cancer survivorship care guidelines (2015)
●American Society for Gastrointestinal Endoscopy (ASGE): Guideline on the role of endoscopy in the staging and management of colorectal cancer (2013)
Europe
●European-African Hepato-Pancreato-Biliary Association (E-AHPBA): The multi-societal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases (2023)
●European Society for Medical Oncology (ESMO): Clinical practice guideline for diagnosis, treatment, and follow-up – Metastatic colorectal cancer (2023)
●ESMO: Clinical practice guidelines for diagnosis, treatment, and follow-up – Localised colon cancer (2020)
●European Society of Surgical Oncology (ESSO), European Society of Coloproctology (ESCP), International Society of Geriatric Oncology (SIOG), and American College of Surgeons (ACS) Commission on Cancer: Expert recommendations for personalized management of elderly patients with rectal cancer (2018)
●ESMO: Clinical practice guidelines for diagnosis, treatment, and follow-up – Rectal cancer (2017)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Diagnostics guidance on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care (2023)
●NICE: Clinical guideline on colorectal cancer prevention – Colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease, or adenomas (2011, updated 2022)
●NICE: Quality standard on colorectal cancer (2012, updated 2022)
●NICE: Guideline on colorectal cancer (2020, updated 2021)
●Scottish Intercollegiate Guidelines Network (SIGN): Diagnosis and management of colorectal cancer − A national clinical guideline (2011, revised 2016)
India
●Japanese Society of Medical Oncology (JSMO), Chinese Society of Clinical Oncology (CSCO), Indian Society of Medical and Paediatric Oncology (ISMPO), Korean Society of Medical Oncology (KSMO), Malaysian Oncological Society (MOS), Singapore Society of Oncology (SSO), and Taiwan Oncology Society (TOS): Pan-Asian adapted European Society for Medical Oncology (ESMO) clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with metastatic colorectal cancer (2023)
●JSMO, CSCO, ISMPO, KSMO, MOS, SSO, and TOS: Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with localised colon cancer (2021)
●Indian Council of Medical Research (ICMR): Consensus document for management of colorectal cancer (2014)
Australia–New Zealand
●Cancer Council Australia: Clinical practice guidelines for the prevention, early detection, and management of colorectal cancer (2017, revised 2023)
•Population screening, update (2023)
•Risk and screening based on family history, update (2023)
●New Zealand Guidelines Group (NZGG): Management of early colorectal cancer – Evidence-based best practice guideline (2011)
Japan
●[In Japanese] Japanese Society for Cancer of the Colon and Rectum (JSCCR): Colorectal cancer treatment guidelines for physicians (2024)
●[In English] Japanese Society of Medical Oncology (JSMO), Chinese Society of Clinical Oncology (CSCO), Indian Society of Medical and Paediatric Oncology (ISMPO), Korean Society of Medical Oncology (KSMO), Malaysian Oncological Society (MOS), Singapore Society of Oncology (SSO), and Taiwan Oncology Society (TOS): Pan-Asian adapted European Society for Medical Oncology (ESMO) clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with metastatic colorectal cancer (2023)
●[In English] JSMO, CSCO, ISMPO, KSMO, MOS, SSO, and TOS: Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with localised colon cancer (2021)
